Sumi Banno

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

Yohei Doi, Masaya Hibino, Ryota Hase et al. · Antimicrobial Agents and Chemotherapy · 2020 · 238 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2

Hidetsugu Fujigaki, Yasuko Yamamoto, Takenao Koseki et al. · Microbiology Spectrum · 2022 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Favipiravir for symptomatic COVID-19: A nationwide observational cohort study

Yohei Doi, Takuma Ishihara, Sumi Banno et al. · Journal of Infection and Chemotherapy · 2022 · 23 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +5

Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect

Yoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita et al. · Japanese Journal of Radiology · 2022 · 18 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +17